Data / Drug companies / Dr. Reddy's Laboratories Limited
Dr. Reddy's Laboratories Limited: 50 products in the FDA NDC directory, labeler code 71796
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Dr. Reddy's Laboratories Limited (labeler code 71796) lists 50 products in the FDA National Drug Code Directory. By type: 48 bulk ingredients, 2 drugs for further processing. Its main marketing category is bulk ingredients. The newest product started marketing on March 20, 2024.
The request: Watch Dr. Reddy's Laboratories Limited (FDA labeler code 71796): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 71796
- Products in commercial distribution
- 50
- Packages
- 60
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- March 29, 2011
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 48 | 96% |
| Drugs for further processing | 2 | 4% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 48 | 96% |
| Drugs for further processing | 2 | 4% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 50 | 100% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Nicotinamide riboside | 71796-068 | Powder | Drugs for further processing | March 20, 2024 |
| Varenicline tartrate | 71796-060 | Powder | Bulk ingredients | August 30, 2023 |
| Cabozantinib hydrochloride | 71796-059 | Powder | Bulk ingredients | March 31, 2023 |
| Lumateperone tosylate | 71796-058 | Powder | Bulk ingredients | March 31, 2023 |
| Ferric carboxymaltose | 71796-054 | Powder | Bulk ingredients | March 29, 2023 |
| Fosaprepitant dimeglumine | 71796-038 | Powder | Bulk ingredients | March 28, 2023 |
| Empagliflozin amorphous | 71796-064 | Powder | Bulk ingredients | December 29, 2022 |
| Ibrutinib | 71796-053 | Powder | Bulk ingredients | November 1, 2022 |
| Tofacitinib | 71796-050 | Powder | Bulk ingredients | July 29, 2022 |
| Nilotinib | 71796-047 | Powder | Bulk ingredients | July 8, 2022 |
| Bempedoic acid | 71796-049 | Powder | Bulk ingredients | March 31, 2022 |
| Empagliflozin | 71796-048 | Powder | Bulk ingredients | March 30, 2022 |
| Siponimod hemifumarate | 71796-045 | Powder | Bulk ingredients | March 30, 2022 |
| Semaglutide | 71796-039 | Powder | Bulk ingredients | December 13, 2021 |
| Losartan potassium (form-1) | 71796-042 | Powder | Bulk ingredients | December 3, 2021 |
| Eribulin mesylate | 71796-044 | Powder | Bulk ingredients | November 30, 2021 |
| Olaparib | 71796-034 | Powder | Bulk ingredients | November 1, 2021 |
| Enalaprilat | 71796-040 | Powder | Bulk ingredients | September 1, 2021 |
| Belumosudil | 71796-066 | Powder | Drugs for further processing | July 16, 2021 |
| Diroximel fumarate | 71796-036 | Powder | Bulk ingredients | March 30, 2021 |
| Apalutamide | 71796-033 | Powder | Bulk ingredients | March 25, 2021 |
| Hydroxychloroquine sulfate | 71796-031 | Powder | Bulk ingredients | February 22, 2021 |
| Sitagliptin phosphate monohydrate | 71796-035 | Powder | Bulk ingredients | February 19, 2021 |
| Lenalidomide | 71796-026 | Powder | Bulk ingredients | December 31, 2020 |
| Clopidogrel bisulfate | 71796-027 | Powder | Bulk ingredients | December 30, 2020 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.